Cited by 411Endometrial and Cervical Cancer TreatmentsBreast Cancer Treatment StudiesOvarian cancer diagnosis and treatment

The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.

Clinical actionability of molecular targets in endometrial cancer

Open access

Urick, Mary Ellen, Bell, Daphne W.·2019·Nature Reviews Cancer

DOI 10.1038/s41568-019-0177-xPMC PMC7446243

Open this paper in CoChat — free account

Abstract

Endometrial cancer accounts for ~76,000 deaths among women each year worldwide. Disease mortality and the increasing number of new diagnoses make endometrial cancer an important consideration in women's health, particularly in industrialized countries, where the incidence of this tumour type is highest. Most endometrial cancers are carcinomas, with the remainder being sarcomas. Endometrial carcinomas can be classified into several histological subtypes, including endometrioid, serous and clear cell carcinomas. Histological subtyping is currently used routinely to guide prognosis and treatment decisions for endometrial cancer patients, while ongoing studies are evaluating the potential clinical utility of molecular subtyping. In this Review, we summarize the overarching molecular features of endometrial cancers and highlight recent studies assessing the potential clinical utility of specific molecular features for early detection, disease risk stratification and directing targeted therapies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41568-019-0177-x

Cites

157 of 157 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
EMT: 2016
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., Srinivasan, P., Gao, J., Chakravarty, D., Devlin, S. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4333 · Cited by 3,380
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
Behan, F. M., Iorio, F., Picco, G., Gonçalves, E., Beaver, C. M., Migliardi, G., Santos, R., Rao, Y., Sassi, F., Pinnelli, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1103-9 · Cited by 1,338
Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer
Talhouk, A., McConechy, M. K., Leung, S. C. Y., Yang, W., Lum, A. M., Senz, J., Boyd, N., Pike, J. A., Anglesio, M. S., Kwon, J. S., et al. (2017) · Cancer · doi:10.1002/cncr.30496 · Cited by 1,007
A clinically applicable molecular-based classification for endometrial cancers
Talhouk, A., McConechy, M. K., Leung, S. C. Y., Li-Chang, H. H., Kwon, J. S., Melnyk, N., Yang, W., Senz, J., Boyd, N., Karnezis, A. N., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.190 · Cited by 989
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
Stelloo, E., Nout, R. A., Osse, E. M., Jurgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C. H. W., van der Steen‐Banasik, E. M., Nijman, H. W., Putter, H., Bosse, T., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2878 · Cited by 856

Show all 157 references

Sorted by citations

Items 201–300 of 411

From Infection to Malignancy: Tracing the Impact of Human Papillomavirus on Uterine Endometrial Cancer in a Nationwide Population-Based Cohort Study
Wu, P., Tsai, S. C., Huang, J., Lee, M., Wang, P.-H., & Lin, F. C. (2023) · Viruses · doi:10.3390/v15122314 · Cited by 7
DOCK1 regulates the malignant biological behavior of endometrial cancer through c-Raf/ERK pathway
Xie, S., Jin, Y., Wang, J., Li, J., Peng, M., & Zhu, X. (2024) · BMC Cancer · doi:10.1186/s12885-024-12030-1 · Cited by 7
Significance of the neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, and platelet-lymphocyte ratio in peripheral blood for endometrial cancer
Huo, D. (2024) · American Journal of Translational Research · doi:10.62347/qnhr2387 · Cited by 8
Ion Channels in Endometrial Cancer
Costa, B. P., Nunes, F. B., Noal, F. C., & Branchini, G. (2022) · Cancers · doi:10.3390/cancers14194733 · Cited by 8
Biomarkers discovery for endometrial cancer: A graph convolutional sample network method
Wu, E., Fan, X., Tang, T., Li, J., Wang, J., Liu, X., Zungar, Z., Ren, J., Wu, C., & Shen, B. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106200 · Cited by 7
Advances in targeting of miR‑10‑associated lncRNAs/circRNAs for the management of cancer (Review)
Gao, S., Liu, S., Wei, W., Qi, Y.-X., & Meng, F. (2023) · Oncology Letters · doi:10.3892/ol.2023.13675 · Cited by 7
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT)
Li, Y., Zhu, C., Xie, H., Chen, Y., Lv, W., Xie, X., & Wang, X. (2023) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2023.34.e37 · Cited by 7
Low‐Density Lipoprotein Contributes to Endometrial Carcinoma Cell Proliferation, Migration, and Invasion by Activating the JAK–STAT Signaling Pathway
Shen, L., Zhang, C., Cui, K., Liang, X., & Zhu, G. (2023) · Analytical Cellular Pathology · doi:10.1155/2023/4015167 · Cited by 7
A Prediction Model of Endometrial Cancer Lesion Metastasis under Region of Interest Target Detection Algorithm
Xu, Y., & Zhao, R. (2021) · Scientific Programming · doi:10.1155/2021/9928842 · Cited by 7
Significance of HER2 and VEGFR2 in Early-stage Endometrial Cancer
An, H. J., Song, D. H., KIM, Y.-M., Jo, H. C., Baek, J. C., & Park, J. E. (2022) · In Vivo · doi:10.21873/invivo.12758 · Cited by 7
Endothelial cell-specific molecule 1 (ESM1) promoted by transcription factor SPI1 acts as an oncogene to modulate the malignant phenotype of endometrial cancer
He, Y., Lin, L., Ou, Y., Hu, X., Xu, C., & Wang, C. (2022) · Open Medicine · doi:10.1515/med-2022-0529 · Cited by 7
A Slug‐dependent mechanism is responsible for tumor suppression of p53‐stabilizing compound CP‐31398 in p53‐mutated endometrial carcinoma
Liu, L., Yu, Z., Yu, T., Cui, S., Yang, L., Chang, H., Qu, Y., Lv, X., Zhang, X., & Ren, C. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29720 · Cited by 7
Incidence of endometrial cancer in BRCA mutation carriers
Kotsopoulos, J., Lubiński, J., Huzarski, T., Bychkovsky, B., Møller, P., Kim, R. H., Tung, N., Eisen, A. F., Foulkes, W. D., Singer, C. F., et al. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.07.687 · Cited by 6
FBXO17 Inhibits the Wnt/β-Catenin Pathway and Proliferation of Ishikawa Cells
Zheng, Z., Wang, Y., Chen, M., Yang, H., Lai, Z., Li, M., & Shao, J. (2022) · International Journal of Medical Sciences · doi:10.7150/ijms.60335 · Cited by 7
A novel machine learning-based programmed cell death-related clinical diagnostic and prognostic model associated with immune infiltration in endometrial cancer
Xiong, J. P., Chen, J., Guo, Z., Zhang, C., Li, Y., & Gao, K. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1224071 · Cited by 6
Enhanced Diagnostic Efficiency of Endometrial Carcinogenesis and Progression in Women with Abnormal Uterine Bleeding through Peripheral Blood Cytokine Testing: A Multicenter Retrospective Cohort Study
Ma, J., Liu, D., Mao, X., Huang, L., Ren, Y., Xu, X., Huang, X., Deng, C., Shi, F., & Sun, P. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.91506 · Cited by 6
A Primer on the Role of TP53 Mutation and Targeted Therapy in Endometrial Cancer
Zhang, B., Zhang, H., & Qin, Y. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl25447 · Cited by 6
CPA4 overexpression correlates with poor prognosis and tumor progression in endometrial cancer
He, K., Zheng, J., Zhang, T., Lv, H., Wang, K., Wang, Z., Wang, L., Wu, S., & Zhao, L. (2025) · European journal of medical research · doi:10.1186/s40001-025-02293-0 · Cited by 6
Fructose‐1,6‐bisphosphate induces generation of reactive oxygen species and activation of p53‐dependent cell death in human endometrial cancer cells
Costa, B. P., Nassr, M. T., Diz, F. M., Carlessi, L. P., Antunes, K. H., Nunes, F. B., Branchini, G., & de Oliveira, J. R. (2020) · Journal of Applied Toxicology · doi:10.1002/jat.4091 · Cited by 7
Comprehensive Study of Human FBXW7 Deleterious nsSNP’s Functional Inference and Susceptibility to Gynaecological Cancer
Vasuki, K. A., & Christy, J. (2021) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-021-03759-7 · Cited by 6
Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis
Miao, C., Fang, X., Chen, Y., Zhao, Y., & Guo, Q. (2021) · Medicine · doi:10.1097/md.0000000000027689 · Cited by 6
Pelvic Carcinosarcoma Showing a Diverse Histology and Hierarchical Gene Mutation with a Common POLE Mutation to Endometrial Endometroid Carcinoma: A Case Report
Kitazono, I., Akahane, T., Kobayashi, Y., Yanazume, S., Tabata, K., Tasaki, T., Noguchi, H., Kirishima, M., Higashi, M., Kobayashi, H., et al. (2022) · International Journal of Surgical Pathology · doi:10.1177/10668969221088880 · Cited by 6
High expression of TARS is associated with poor prognosis of endometrial cancer
Si, L., Liu, L., Yang, R., Li, W., & Xu, X. (2023) · Aging · doi:10.18632/aging.204558 · Cited by 6
PBX1-promoted SFRP4 transcription inhibits cell proliferation and epithelial-mesenchymal transition in endometrial carcinoma
Guo, L., Chen, H., Chen, J., Gao, C., Wu, W., Zhou, S., Wu, W., Li, T., Lin, J., Yang, T., et al. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102083 · Cited by 6
Identification of Potentially Novel Molecular Targets of Endometrial Cancer Using a Non-Biased Proteomic Approach
Taylor, A. H., Konje, J. C., & Ayakannu, T. (2023) · Cancers · doi:10.3390/cancers15184665 · Cited by 6
PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis
Yang, X. F., Liu, Z., Tang, W., Pratap, U. P., Collier, A. B., Altwegg, K. A., Gopalam, R., Li, X., Yuan, Y., Zhou, D., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13539 · Cited by 6
Development and validation of a nomogram for predicting recurrence-free survival in endometrial cancer: a multicenter study
Li, Y., Hou, X., Chen, W., Wang, S., & Ma, X. (2023) · Scientific Reports · doi:10.1038/s41598-023-47419-8 · Cited by 6
Computational analysis of regulatory genes network pathways among devastating cancer diseases
Taz, T. A., Kawsar, M., Paul, B. K., & Ahmed, K. (2020) · Journal of Proteins and Proteomics · doi:10.1007/s42485-020-00032-z · Cited by 6
Analysis of m6A methylation patterns and tumor microenvironment in endometrial cancer
Chen, J., Luo, X., Wang, G., Zhang, J., & Zhang, Y. (2022) · Gene · doi:10.1016/j.gene.2022.147052 · Cited by 6
Molecular diversity in uterine carcinosarcoma: Beyond TP53
Pham, E. N. B., van den Berg, C. B., Kokke, N., van Marion, R., Dollée, D., Boere, I. A., Groenendijk, F. H., & van Beekhuizen, H. J. (2025) · Gynecologic Oncology · doi:10.1016/j.ygyno.2025.05.010 · Cited by 5
Fanconi anemia complementation group D2 promotes sensitivity of endometrial cancer cells to chemotherapeutic agents by inhibiting the ferroptosis pathway
Lin, H., Zeng, W., Yang, H., Huang, L., Pan, R., & Lei, N. (2024) · BMC Women s Health · doi:10.1186/s12905-023-02857-4 · Cited by 5
The relationship between HPV testing attitudes and beliefs, knowledge, and vaccination attitudes: A cross‐sectional study
Küçükkaya, B., SÖGÜT, S. C., & Cangöl, E. (2024) · Public Health Nursing · doi:10.1111/phn.13390 · Cited by 5
T-Box Transcription Factor 2 Mediates Chemoresistance of Endometrial Cancer via Regulating FSP1-involved Ferroptosis
Yu, X., Yao, X., Song, F., & Zhu, X. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01518-z · Cited by 5
Minimally Invasive and Emerging Diagnostic Approaches in Endometrial Cancer: Epigenetic Insights and the Promise of DNA Methylation
Porcaro, F., Paolucci, A., Porcaro, P., Cardinale, G., Romitelli, A., Cozzolino, D., & Voccola, S. (2024) · Diagnostics · doi:10.3390/diagnostics14222575 · Cited by 5
Molecular subtyping of endometrial cancer via a simplified one-step NGS classifier, ARID1A and ZFHX4 mutations help further subclassify CNL/MSI-H patients
Teng, Q., Yuan, Z., Mu, Y., Ma, X., Wang, S., Sun, C., Chin, L., Huang, Z., Zhu, C., Yin, A., et al. (2025) · Diagnostic Pathology · doi:10.1186/s13000-025-01652-z · Cited by 5
Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential
Acland, M., Arentz, G., Mussared, M., Whitehead, F., Hoffmann, P., Klingler‐Hoffmann, M., & Oehler, M. K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.523989 · Cited by 5
Relationship between the Metabolic Associated Fatty Liver Disease and Endometrial Thickness in Postmenopausal Women: A Cross-sectional Study in China
Wei, J., Xu, Z., Li, H., Du, W.-Q., Niu, B.-L., Li, S., Tian, S., Wu, J., Chen, Y., Li, X., et al. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.60780 · Cited by 5
Integrated Bioinformatics Analysis of Serine Racemase as an Independent Prognostic Biomarker in Endometrial Cancer
Cui, Z., Mo, J., Wang, L., Wang, R., Cheng, F., Wang, L., Yang, X., & Wang, W. T. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.906291 · Cited by 5
Comprehensive Approach to Genomic and Immune Profiling: Insights of a Real-World Experience in Gynecological Tumors
Prieto‐Potín, I., Idrovo, F., Suárez‐Gauthier, A., Díaz-Blázquez, M., de Córdova, L. A. B., Chamizo, C., Zazo, S., Carvajal, N., López‐Sánchez, A., Pérez‐Buira, S., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12081903 · Cited by 5
Tamoxifen Regulates Epithelial–Mesenchymal Transition in Endometrial Cancer via the CANP10/NRP1 Signaling Pathway
Lv, Y., & Xu, L. (2022) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00530 · Cited by 5
Integrative models of histopathological images and multi-omics data predict prognosis in endometrial carcinoma
Li, Y., Du, P., Zeng, H., Wei, Y., Fu, H., Zhong, X. Z., & Ma, X. (2023) · PeerJ · doi:10.7717/peerj.15674 · Cited by 7
Insights into MLH1 Methylation in Endometrial Adenocarcinoma through Pyrosequencing Analysis: A Retrospective Observational Study
Silva, F. F. V. E., Ballini, A., Caponio, V. C. A., Pérez‐Sayáns, M., Gándara‐Cortés, M., Rojo-Álvarez, L. I., Garcı́a, A. G., Peñaranda, J. M. S., Domenico, M. D., & Padín-Iruegas, E. (2024) · Cancers · doi:10.3390/cancers16112119 · Cited by 5
A deep learning framework for predicting endometrial cancer from cytopathologic images with different staining styles
Wang, R., Li, Q., Shi, G., Li, Q., & Zhong, D. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306549 · Cited by 5
Histomolecular features of high-grade endometrial cancers
Morotti, M., majd, H. S., Casarin, J., Alazzam, M., & Damato, S. (2021) · Minerva Medica · doi:10.23736/s0026-4806.20.07082-2 · Cited by 5
Case Report: Double Germline Mutations in BRCA1 and MSH2 in a Patient With Mixed Serous-Endometrioid Endometrial Carcinoma
Zheng, H., Yuan, M., Wu, H., Chen, R., & Gao, Y. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.581982 · Cited by 4
Explainable machine learning for preoperative relapse prediction in molecularly stratified endometrial cancer: A single-center finnish cohort study
Moreno, S. V., Khatun, M., Pasanen, A. M., Bützow, R. C., Salumets, A., Loukovaara, M. J., & Modhukur, V. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.12.018 · Cited by 4
Identifying the Role of Disulfidptosis in Endometrial Cancer via Machine Learning Methods
Fu, F., Lu, X., Zhang, Z., Li, Z., & Xie, Q. (2023) · BioMedInformatics · doi:10.3390/biomedinformatics3040056 · Cited by 4
Phosphocholine inhibits proliferation and reduces stemness of endometrial cancer cells by downregulating mTOR-c-Myc signaling
Gong, K., Zheng, Y., Liu, Y., Zhang, T., Song, Y., Chen, W., Guo, L., Zhou, J., Liu, W., Fang, T., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05517-4 · Cited by 4
Characterization of G2/M checkpoint classifier for personalized treatment in uterine corpus endometrial carcinoma
Liu, Y., Wang, Y., Tan, S., Shi, X., Wen, J., Chen, D., Zhao, Y., Pan, W., Jia, Z., Lu, C., et al. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03667-4 · Cited by 4
GWAS meta-analysis identifies five susceptibility loci for endometrial cancer
Ramachandran, D., Wang, X. M., Laisk, T., Zheng, Y., Ingold, N., Canson, D. M., Kho, P. F., Naumann, B. J., Chapman, C. J., Bousset, K., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105830 · Cited by 4
The involvement of lncRNA EMSLR in the disulfidptosis and progression of endometrial carcinoma
Sun, Y., Wang, R., Li, X., Zhou, W., Huang, H., Zhou, Y., Zhu, X., Yin, Y., & Teng, Y. (2025) · Cancer Gene Therapy · doi:10.1038/s41417-025-00918-4 · Cited by 4
Endometrial carcinoma: association between mutational status, sites of metastasis, recurrence, and correlation with overall survival
Luna, C., Goncalves, N., Metalonis, S. W., Mason, M. M., Lyu, J., Huang, M. S., & Alessandrino, F. (2023) · Abdominal Radiology · doi:10.1007/s00261-023-03973-3 · Cited by 4
Determination of endometrial cancer molecular subtypes using a whole exome-sequencing based single-method approach
Mustea, A., Ralser, D. J., EGGER, E. K., Ziehm, U., Vivas, S., Brock, S., Jackson, D., Condic, M., Rauschendorf, M., Würfel, P., et al. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05901-4 · Cited by 4
Establishment and verification of a prognostic signature associated with fatty acid metabolism in endometrial cancer
Peng, L., Sun, R., Hao, T., Mu, Y., Zhang, Q., Jiang, J., Schiöth, H. B., & Dong, R. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13444 · Cited by 4
Regulatory patterns analysis of transcription factor binding site clustered regions and identification of key genes in endometrial cancer
Tang, X., Wang, J., Tao, H., Yuan, L., Du, G., Ding, Y., Xu, K., Bai, X., Li, Y., Sun, Y., et al. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.01.014 · Cited by 4
A Novel Defined Pyroptosis-Related Gene Signature for Predicting the Prognosis of Endometrial Cancer
Liu, S., Zeng, C., Lv, H., Zhang, Y., Xiong, H., & Tang, H. (2022) · Disease Markers · doi:10.1155/2022/7570494 · Cited by 4
The Roles of TP53 and FGFR2 in Progress Made Treating Endometrial Cancer
Adamczyk-Gruszka, O. K., Horecka-Lewitowicz, A., Strzelecka, A., Wawszczak-Kasza, M., Gruszka, J., & Lewitowicz, P. (2022) · Diagnostics · doi:10.3390/diagnostics12071737 · Cited by 4
Comparison of two suspension injection tracers of nano activated carbon and methylene blue in mapping and tracing of sentinel lymph nodes of patients with endometrial cancer
Zhang, W., Shu, Y., Ni, D., Wan, Z., & Yang, S. (2022) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.38.6.5714 · Cited by 4
Beyond Serous: Treatment Options for Rare Endometrial Cancers
Crane, E. K. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-01014-7 · Cited by 4
Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma
Ma, L., Li, Y., Wu, J., & Gao, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-85364-w · Cited by 3
A Cxcl15 Cre Recombinase Mouse Model Useful to Study Gland Development in the Uterus
Kelleher, A. M., Kim, H. I., Bayammagari, G. S., Davis, D. J., & Spencer, T. E. (2025) · genesis · doi:10.1002/dvg.70026 · Cited by 3
Prevalence of high-grade endometrioid endometrial cancer of no specific molecular profile (NSMP): A systematic review and meta-analysis
Casanova, J., Ramos, A. S. B. F., Babiciu, A., Moutinho, F. S., Tripepi, M., da Costa, A. G., Serra, S. S., Costa, T., Abu‐Rustum, N. R., Martins, J. P., et al. (2025) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2025.114794 · Cited by 3
Integrated Identification and Immunotherapy Response Analysis of the Prognostic Signature Associated With m6A , Cuproptosis‐Related, Ferroptosis‐Related lncRNA in Endometrial Cancer
Qian, Y., Chen, H., Miao, P., Ma, R., Lu, B., Hu, C., Fan, R., Xu, B., & Chen, B. (2024) · Cancer Reports · doi:10.1002/cnr2.70009 · Cited by 3
Study on the expression of S100A4 and HMGA1 in endometrial carcinoma and their correlation with metastasis
Pei, X. (2025) · American Journal of Translational Research · doi:10.62347/qibf6088 · Cited by 3
p53abn high-risk endometrial cancer with PPP2R1A mutation might not benefit from adjuvant chemotherapy
Zhang, Q., Wang, Y., He, D., Sun, J., Li, X., Li, D., Dong, Y., Zhang, Y., & Wang, S. (2025) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaf039 · Cited by 3
Multiple roles and mechanisms of MUC6 in cancer (Review)
Luo, X., Fu, X., Xiong, Y., & Xiao, P. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5629 · Cited by 3
Expression of the Hippo Pathway Core Components in Endometrial Cancer and Its Association with Clinicopathologic Features
Yang, J., Song, D. H., Kim, C. H., Kim, M. H., Jo, H. C., Kim, H., Park, J. E., & Baek, J. C. (2022) · Diagnostics · doi:10.3390/diagnostics12122973 · Cited by 3
A review of basic to clinical targeted therapy and immunotherapy in uterine serous cancer
Sun, B., Zhao, N., Cheng, Y., & Wang, J. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08580-5 · Cited by 3
A novel epithelial–mesenchymal transition-related lncRNA signature predicts prognosis and immune status in endometrioid endometrial cancer
Jin, Y., Qiu, Y., Li, Y., Jiang, Z., Hu, S., & Dai, H. (2023) · Medicine · doi:10.1097/md.0000000000034126 · Cited by 3
Diagnostic Potential of Endometrial Cancer DNA from Pipelle, Pap-Brush, and Swab Sampling
Wang, Y., Du, H., Dai, W., Bao, C., Zhang, X., Hu, Y., Xie, Z., Zhao, X., Li, C., Zhang, W., et al. (2023) · Cancers · doi:10.3390/cancers15133522 · Cited by 3
Construction of an immune-related gene prognostic model for obese endometrial cancer patients based on bioinformatics analysis
Tong, Y., Zhu, T., Xu, F., Yang, W., Wang, Y., Zhang, X., Chen, X., & Liu, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35488 · Cited by 3
Hysterectomy or/and lymphadenectomy for the survival of patients with primary endometrial cancer: a cohort study using the SEER database
Min, Y., & Zhang, Z. (2022) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2022.2162235 · Cited by 3
Human papillomavirus and endometrial cancer (review of literature and meta-analysis)
Ibragimova, M. K., Kokorina, E. V., Tsyganov, M. M., Чуруксаева, О. Н., & Литвяков, Н. В. (2020) · Tumors of female reproductive system · doi:10.17650/1994-4098-2020-16-4-91-99 · Cited by 3
Use of the vessel sealer in paraaortic lymphadenectomy in the robotic assisted approach in endometrial cancer
Bizoń, M., Olszewski, M., Grabowska, A. K., Siudek, J., Mawlichanów, K., & Pilka, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-93044-y · Cited by 2
Integrating multi-omics data to optimize immunotherapy in endometrial cancer: a comprehensive study
Guan, X., Cao, R., Liu, L., Ma, L., Gao, N., Yang, Y., Xiao, M., Du, R., Su, Y., Wang, Z., et al. (2025) · Discover Oncology · doi:10.1007/s12672-025-02978-2 · Cited by 2
Bioinformatics Analysis Identifies Lipid Droplet‐Associated Gene Signatures as Promising Prognostic and Diagnostic Models for Endometrial Cancer
Ayyagari, V. N., Li, M., Díaz‐Sylvester, P., Groesch, K. A., Wilson, T., Shah, E., & Brard, L. (2025) · Cancer Reports · doi:10.1002/cnr2.70313 · Cited by 2
Molecular mechanisms of natural polysaccharides in female-prevalent cancers
Li, H., Jiang, M., Fan, Y., Shen, Y., Han, Y., Xu, H., Cai, B., & Chen, M. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157340 · Cited by 2
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression
Kadry, M. O., Serag, A., & Ammar, N. M. (2025) · Cancer Cell International · doi:10.1186/s12935-025-04014-3 · Cited by 2
Tight junction disruption via claudin-6 overexpression promotes invasion and recurrence in high-grade endometrial tumors
Ebrahim, N. A. A., Eissa, T. S., Hussein, M. A., Korany, O. M., & Amin, N. H. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i11.110257 · Cited by 2
Knockdown of LMTK3 in the Endometrioid Adenocarcinoma Cell Line Ishikawa: Inhibition of Growth and Estrogen Receptor α
Cai, G., Sun, W., Bi, F., Wang, D., & Yang, Q. F. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.692282 · Cited by 2
Role of miR-15b/16–2 cluster network in endometrial cancer: An in silico pathway and prognostic analysis
Kallingal, A., Thankachan, S., Venkatesh, T., Kabekkodu, S. P., & Suresh, P. S. (2022) · Meta Gene · doi:10.1016/j.mgene.2022.101018 · Cited by 2
Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study
Tian, Y., Ran, L., Liu, Y., Xu, Y. M., Shen, J., Mi, G.-S., & Ke, F.-M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.800957 · Cited by 2
Histopathological Evaluation and Molecular Diagnostic Tests for Peritoneal Metastases with Unknown Primary Site—a Review
Bhatt, A., Mishra, S. R., & Gléhen, O. (2022) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-022-01612-9 · Cited by 2
Nuclear Expression of β-Catenin Is Associated with Improved Outcomes in Endometrial Cancer
Masciullo, V., Susini, T., Corrado, G., Stepanova, M., Baroni, A., Renda, I., Castiglione, F., Minimo, C., Bellacosa, A., Chiofalo, B., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12102401 · Cited by 2
Clinical characterization and genomic landscape of gynecological cancers among patients attending a Chinese hospital
Jiang, C., Lu, Y., Liu, H., Cai, G., Peng, Z., Feng, W., & Lin, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1143876 · Cited by 2
The Emerging Role of MicroRNAs in Female Reproductive Diseases
Liu, M., Xiao, B., Zhu, Y., Chen, M., Huang, J., Cao, Q., & Wang, F. (2023) · Journal of Clinical Medicine Current Research · doi:10.53043/2832-7551.jcmcr.3.013 · Cited by 2
Retrospective Analysis of Molecular Markers in Endometrial Cancer: Single Center Experience
Özdemir, C. Y., Arıöz, D. T., Çiçekli, N., Chkhikvadze, M., Bilir, F., Demir, H., Demir, H., & Söylemez, E. S. A. (2024) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5102043 · Cited by 2
Knockdown of S100A2 inhibits the aggressiveness of endometrial cancer by activating STING pathway
Li, C., Zhu, D., Cao, X., Li, Y., & Hao, X.-Y. (2024) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2024.2361849 · Cited by 2
Identification of hub genes and pathways in Uterine corpus endometrial carcinoma (UCEC): A comprehensive in silico study
Ejlalidiz, M., Ghahfarrokhi, A. M., & Saberiyan, M. (2024) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2024.101860 · Cited by 2
E2F1-induced upregulation of TROAP contributes to endometrial cancer progression.
Wang, S., Sun, Y., Guo, M., Xin, B., & Zhu, P. (2025) · PubMed · doi:10.14670/hh-18-834 · Cited by 2
Identification of key genes underlying radiosensitivity and radioresistance in endometrial cancer through integrated bioinformatics analysis
Wan, C., Zhang, L., Yu, T., Lü, H., Xiao, H., & Du, J. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1469610 · Cited by 2
Targeting TSPAN1 promotes ferroptosis in endometrial cancer cells, reduces energy metabolism and inhibits malignant behavior
Yang, F., Xiao, H., Wu, Y., Yan, R., Li, P., & Ma, H. (2025) · Gene · doi:10.1016/j.gene.2025.149553 · Cited by 2
The Prognosis Prediction Model for Endometrial Cancer Based on DNA Methylation Signature
Ran, R., Wang, M., & Miao, J. (2025) · Cancer Reports · doi:10.1002/cnr2.70218 · Cited by 2
Multi-omics analysis of the anti-cancer effects of curcumol in endometrial carcinoma
Xie, J., Zhu, Y., Bai, H., Song, Z., Qiu, S., Xie, Y., & Wan, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1565959 · Cited by 2
Identification of methylation-related genes and the potential regulatory mechanism of SLAMF6 in CMS4 colorectal cancer
Liu, H., Yang, J., Zhao, C., Wang, G., Lu, R., & Wang, X. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01953-6 · Cited by 2
Integrating homologous recombination deficiency subtyping with TCGA molecular classification for enhanced prognostic stratification and personalised therapy in endometrial cancer
Wang, W., Gao, M., Gao, Y., Zheng, H., Song, N., Zhang, N., Shu, T., Gao, W., Zhang, N., & Wang, H. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03179-y · Cited by 2
lncRNA LINC00958 Activates NOTCH3 by Competitively Inhibiting miR‐129‐2‐3p to Exacerbate the Malignant Biological Behaviors of Endometrial Cancer Cells
Hong, X., & He, S. D. (2025) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.70081 · Cited by 2
KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas
Rudd, M. L., Hansen, N. F., Zhang, X., Urick, M. E., Zhang, S., Merino, M. J., Mullikin, J. C., Brody, L. C., & Bell, D. W. (2022) · PLoS ONE · doi:10.1371/journal.pone.0251286 · Cited by 2
Self-citation
Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity
Nian, Y., Li, X., Ma, J., Gao, T., & Liu, D. (2022) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2023.34.e11 · Cited by 2
Retracted
Prognostic Role of Oncogenic and Tumor-Suppressing miRNA Types in Egyptian Uterine Cancer Patients
Salim, E. I., Beltagy, D. M., Elmashad, N. M., & Abodonia, M. (2022) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2022.23.8.2607 · Cited by 2

Authors: Urick, M. E., & Bell, D. W.
Affiliations: National Institutes of Health (US)
Corresponding author: Bell, Daphne W.
ORCID: Urick, Mary Ellen
Bell, Daphne W.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2019-08-06
Volume: 19
Issue: 9
Pages: 510-521
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/s41568-019-0177-x
PMC: PMC7446243
OpenAlex: W2965204233
Cited by: 405
References: 157
Citations by year: 2026: 19 · 2025: 57 · 2024: 58 · 2023: 70 · 2022: 101 · 2021: 66 · 2020: 32 · 2019: 2
FWCI: 8.14
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (Z99 HG999999)
National Human Genome Research Institute (Z01HG200338, ZIAHG200379, ZIAHG200338)
Topics: Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
Keywords: endometrial cancer, molecular subtyping, molecular targets, targeted therapy, early detection, risk stratification, endometrioid carcinoma, serous carcinoma, clear cell carcinoma, histological subtypes, prognosis
MeSH terms: Animals, Carcinoma, Female, Humans, Immunotherapy, Mutation, Prognosis, Risk, Sarcoma, Biomarkers, Tumor, Endometrial Neoplasms, Risk Assessment, Proteomics, Mice, Translational Research, Biomedical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical actionability of molecular targets in endometrial cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks